Загрузка...
A systematic review of the budget impact analyses for antitumor drugs of lung cancer
BACKGROUND: Budget impact analyses (BIAs) are used for reimbursement decisions and drug access medical insurance, as a supplement to cost-effectiveness analyses (CEAs). OBJECTIVES: We systematically reviewed BIAs for antitumor drugs of lung cancer to provide reference for high-value drug budget impa...
Сохранить в:
| Опубликовано в: : | Cost Eff Resour Alloc |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7706257/ https://ncbi.nlm.nih.gov/pubmed/33292288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-020-00253-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|